Chain Bridge Bancorp vs National Bank
CBNA and NBHC side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CBNA and NBHC compare
National Bank is the larger company, worth 4.8 times as much as Chain Bridge Bancorp ($1.6B against $342M).
On earnings, Chain Bridge Bancorp is cheaper: it trades at 12.8× trailing earnings, against 15.3× for National Bank.
Chain Bridge Bancorp grew revenue faster over the last twelve months (15.4% versus 7.3% for National Bank).
National Bank keeps more of each dollar of sales as profit, with a net margin of 203% compared with 40.9% at Chain Bridge Bancorp.
National Bank pays a dividend yielding 3.5%; Chain Bridge Bancorp does not pay one.
National Bank scores higher on the StockData Score (11 against 10 for Chain Bridge Bancorp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CBNA | NBHC |
|---|---|---|
| Size and price | ||
| Market cap | $342M | $1.6B |
| Share price | $52.11 | $36.52 |
| Change, 1 year | 71.8% | −0.57% |
| Change, 5 years | – | −16.3% |
| Beta (5Y) | 0.44 | 0.37 |
| Employees | 84 | 1,302 |
| StockData Score | ||
| Total score | 10 | 11 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 1 (better) | 0 |
| Performance score | 3 (better) | 2 |
| Health score | 6 (better) | 4 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 12.8× (better) | 15.3× |
| P/S | 5.2× (better) | 33.5× |
| P/B | 1.9× | 1.0× (better) |
| P/FCF | 20.5× | – |
| PEG | – | 1.64 |
| FCF yield | 4.9% | – |
| Fair value | $39.84 | $37.63 |
| Margin of safety | −30.8% | 2.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 15.4% (better) | 7.3% |
| Revenue growth, 5Y average | – | 7.8% |
| Net income growth (TTM) | 24.3% (better) | −17.5% |
| EPS growth (TTM) | 7.4% (better) | −23.2% |
| EPS growth, 5Y average | – | 0.00% |
| Profitability | ||
| Net margin | 40.9% | 203% (better) |
| FCF margin | 25.6% | – |
| Return on equity | 15.6% (better) | 6.5% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Altman Z-score | 0.20 (better) | 0.16 |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 3.5% |
| Payout ratio | – | 53.3% |
| Years of dividend growth | – | 9 |
| Dividend growth, 5Y average | – | 8.4% |
| Buyback yield | – | 2.3% |
| Shareholder yield | 0.00% | 5.8% (better) |
| Ownership | ||
| Held by institutions | 33.5% | 92.6% |
| Held by insiders | 32.2% | 8.4% |
| Insider net buying, 12 months | −$14.1K | $812K (better) |
| Short interest, % of float | 4.7% | 4.6% |
Go deeper
- CBNA stock overview
- CBNA income statement
- CBNA valuation and score
- NBHC stock overview
- NBHC income statement
- NBHC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.